Raymond James analyst Elliot Wilbur upgraded Perrigo (PRGO) to Outperform from Market Perform with a $59 price target ((PT)), implying a premium of ~31.5% to the last...
Investing.com – U.S. equities were higher at the close on Thursday, as gains in the Basic Materials, Healthcare and Consumer Goods sectors propelled shares higher. At the close in...
Perrigo EVP and Chief Scientific Officer Jim Dillard has been named president of the company's Consumer Self-Care Americas division.
Equity investors will likely seek direction after Friday's disappointing August jobs report amid surging COVID-19 cases in the US, adding another layer of uncertainty to the...
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Sell | Strong Sell | Strong Sell | Sell | Sell |
| Technical Indicators | Strong Sell | Strong Sell | Strong Sell | Sell | Strong Sell |
| Summary | Strong Sell | Strong Sell | Strong Sell | Sell | Strong Sell |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 331.50 | 332.00 | 327.50 | +1.50 | +0.46% | 399.69K | London | |||
| 6.50 | 6.50 | 6.20 | +0.445 | +7.35% | 3.01M | London | |||
| 137.20 | 138.20 | 137.20 | 0.00 | 0.00% | 1.89M | London | |||
| 140.60 | 141.75 | 138.85 | -0.30 | -0.21% | 19.36M | London | |||
| 49.12 | 49.23 | 47.97 | +0.68 | +1.39% | 209.04M | London | |||
| 267.90 | 269.60 | 265.90 | +1.90 | +0.71% | 12.48M | London | |||
| 289.40 | 325.60 | 282.00 | -16.40 | -5.36% | 7.96M | London | |||
| 0.0675 | 0.00 | 0.00 | 0.0000 | 0.00% | 255.13M | London | |||
| 2.52 | 2.52 | 2.52 | -0.05 | -1.94% | 2.63M | London | |||
| 296.80 | 305.40 | 291.80 | +11.00 | +3.85% | 5.74M | London | |||
| 7,908.00 | 7,954.00 | 7,834.00 | +74.0 | +0.94% | 383.53K | London | |||
| 197.82 | 198.82 | 195.40 | +3.42 | +1.76% | 41.18M | London | |||
| 68.60 | 68.80 | 64.40 | +4.50 | +7.02% | 1.73M | London | |||
| 812.00 | 818.50 | 807.50 | +0.50 | +0.06% | 841.56K | London | |||
| 6.60 | 6.60 | 6.60 | +0.800 | +13.79% | 1.96M | London |
Perrigo Company plc is a provider of over the counter (OTC) health and wellness solutions that enables consumers to prevent or treat conditions that can be self-managed. The Company operates through two segments: Consumer Self-Care Americas (CSCA) and Consumer Self-Care International (CSCI). The CSCA segment comprises consumer self-care business (OTC, infant formula, and oral self-care categories, and contract manufacturing) in the United States (U.S), Mexico and Canada. CSCA segment products sold under brands, such as Prevacid 24HR, Good Sense, Zephrex D, ScarAway, Plackers, Rembrandt, Steripod and Firefly. The CSCI segment comprises consumer self-care business primarily branded in Europe and Australia, store brand business in the United Kingdom and parts of Europe and Asia. The CSCI segment primarily focuses on building local and regional brands sold through merchandisers, drug stores, pharmacies and e-commerce channels.